tiprankstipranks
Trending News
More News >
Pharmaron Beijing Co., Ltd. Class H (DE:17Q1)
FRANKFURT:17Q1
Advertisement

Pharmaron Beijing Co., Ltd. Class H (17Q1) Similar Stocks

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Pharmaron Beijing Co., Ltd. Class H
€2.20
€6.06B
24.40
129.17%
3 Buy
0 Hold
0 Sell
Strong Buy
Genscript Biotech
$2.20
$5.22B
0.93
37.50%
2 Buy
0 Hold
0 Sell
Moderate Buy
Zai Lab Ltd
€2.76
€3.25B
71.43%
0 Buy
1 Hold
0 Sell
Hold
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$29.80
HK$46.13B
158.23%
1 Buy
1 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.28
HK$35.73B
37.41
134.63%
1 Buy
0 Hold
0 Sell
Moderate Buy
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
HK$87.25
HK$38.51B
28.35
123.09%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:17Q1
Pharmaron Beijing Co., Ltd. Class H
2.20
1.24
129.17%
GNNSF
Genscript Biotech
2.20
0.60
37.50%
DE:1ZLB
Zai Lab Ltd
2.76
1.15
71.43%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
29.80
18.26
158.23%
HK:2096
Simcere Pharmaceutical Group Limited
13.28
7.64
135.46%
HK:6821
Asymchem Laboratories (Tianjin) Co., Ltd. Class H
87.25
47.26
118.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis